Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Main P, Angley MT, O'Doherty CE, Thomas P, Fenech M
Sullivan, Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare, Value in Health, 10.1016/j.jval.2025.07.007, 28 , 10, (1488-1496), (2025)
Effects of SGLT-2 inhibitors on clinical and biological hyperandrogenism and menstruation irregularities in patients with polycystic ovary syndrome: a systematic review of randomized trials
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
US$ 29.91
US$ 22.54
US$ 28.15
US$ 29.92
